*NEWS: Axonics Drops In IPO

This article is courtesy of SoCal Tech, with whom OCSN has a partnership with:
Irvine-based Axonics Modulation Technologies, which is developing medical devices for treating overactive bladder, fecal incontinence and urinary retention, has had its IPO debut, pricing its IPO last night at $15.00 per share. The company’s stock dropping in trading on Wednesday, falling to around $14.85 in afternoon trading. Axonics sold 8,000,000 shares of its common stock in the offering. The company is now trading as AXNX on the Nasdaw Global Select market.

About The Author

Deirdre Newman is a long-time journalist, who's covered OC startups for a few years.

You don't have permission to register